Home > Insider Trading > Filing (0001209191-20-012027)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645460	Cue Biopharma Inc.	CUE	Pharmaceutical Preparations (2834)	473324577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1724870	Colin Sandercock	21 Erie Street Cambridge MA 02139	Svp, General Counsel And Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-07	100	$7.35	2,100	No	4	P	Direct
Common Stock	Acquisiton	2019-06-10	15,025	$7.90	17,125	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

This transaction was inadvertantly omitted from the reporting person's original Form 4 filed on June 10, 2019 (the "Original Form 4").
87 of these shares were inadvertantly omitted from the Original Form 4, which reported a purchase of 14,938 shares of common stock on June 10, 2019 at a weighted average price of $7.93.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.85 to $7.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4.